Estimation of fine-scale spatial heterogeneity in treatment effects in a large cluster-randomized trial
- 1Francis I Proctor Foundation, University of California San Francisco
Abstract
Treatment effects in randomized trials may vary geographically, and estimating this variation is a broadly generalizable problem for large-scale, cluster-randomized trials. We conducted a secondary analysis of AVENIR, a cluster-randomized, placebo-controlled trial of biannual azithromycin distribution among children aged 1-59 months in Dosso, Niger (2020-2023). We assessed whether the survival benefit of mass azithromycin distribution varied geographically using Poisson models to estimate spatially continuous child mortality and average treatment effects (ATE). Among 1390 villages (276,452 person-years; 3635 deaths), the overall mortality rate was 13.1 and the ATE was -2.6 deaths per 1000 person-years. Mortality was highest in the south, whereas treatment benefit was concentrated in the southeast, following a northwest-southeast gradient. Aggregation of data to 160 primary health catchment areas preserved broad spatial patterns in mortality but attenuated local heterogeneity, suggesting that health catchment monitoring is sufficient for broad mortality surveillance. Examining unit-level, spatially predicted treatment effects as a function of mortality rate demonstrated that underlying mortality captured much, but not all, of the heterogeneity in treatment effects. The analysis demonstrates how to estimate localized treatment effects in large cluster-randomized trials and provides new insights into spatial heterogeneity in mortality and benefits of azithromycin distribution in Niger.
Related
- Spatial/molecular heterogeneity and treatment response in HER2+ early breast cancer: Translational analyses from the DAPHNe trial
- A lay teacher-counsellor delivered brief psychological treatment for moderate to severe depression among older adolescents in senior high schools in Ghana (Y-MIND): a feasibility cluster randomized controlled trial
- Effect of a person-centered care intervention on return and sustained reengagement after treatment interruptions from HIV care in Zambia: A post-hoc analysis of a stepped-wedged cluster randomized trial
- Spatiotemporal evolution and spatial heterogeneity of driving factors of gonorrhea incidence in Mainland China before and after the COVID-19 pandemic
- Multimodal spatial-omics reveal the heterogeneity and intercellular network characteristics of papillary craniopharyngiomas.
BibTeX
@misc{srivathsan2026estimation,
title = {{Estimation of fine-scale spatial heterogeneity in treatment effects in a large cluster-randomized trial}},
author = {A. Srivathsan and M. A. Navarro and A. M. Arzika and A. Abdou and R. Maliki and A. Ibrahim and D. Beidi and N. Galo and N. Harouna and A. M. Karamba and M. Abarchi and B. Peterson and P. A. Ante-Testard and E. Lebas and T. C. Porco and M. Lipsitch and K. S. O'Brien and T. M. Lietman and B. F. Arnold},
howpublished = {medRxiv},
year = {2026},
month = nov,
doi = {10.64898/2026.11.03.26367216},
url = {https://www.medrxiv.org/content/10.64898/2026.11.03.26367216v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - Estimation of fine-scale spatial heterogeneity in treatment effects in a large cluster-randomized trial
AU - A. Srivathsan
AU - M. A. Navarro
AU - A. M. Arzika
AU - A. Abdou
AU - R. Maliki
AU - A. Ibrahim
AU - D. Beidi
AU - N. Galo
AU - N. Harouna
AU - A. M. Karamba
AU - M. Abarchi
AU - B. Peterson
AU - P. A. Ante-Testard
AU - E. Lebas
AU - T. C. Porco
AU - M. Lipsitch
AU - K. S. O'Brien
AU - T. M. Lietman
AU - B. F. Arnold
PY - 2026
DA - 2026/11/03
PB - medRxiv
DO - 10.64898/2026.11.03.26367216
UR - https://www.medrxiv.org/content/10.64898/2026.11.03.26367216v1
AB - Treatment effects in randomized trials may vary geographically, and estimating this variation is a broadly generalizable problem for large-scale, cluster-randomized trials. We conducted a secondary analysis of AVENIR, a cluster-randomized, placebo-controlled trial of biannual azithromycin distribution among children aged 1-59 months in Dosso, Niger (2020-2023). We assessed whether the survival benefit of mass azithromycin distribution varied geographically using Poisson models to estimate spatially continuous child mortality and average treatment effects (ATE). Among 1390 villages (276,452 person-years; 3635 deaths), the overall mortality rate was 13.1 and the ATE was -2.6 deaths per 1000 person-years. Mortality was highest in the south, whereas treatment benefit was concentrated in the southeast, following a northwest-southeast gradient. Aggregation of data to 160 primary health catchment areas preserved broad spatial patterns in mortality but attenuated local heterogeneity, suggesting that health catchment monitoring is sufficient for broad mortality surveillance. Examining unit-level, spatially predicted treatment effects as a function of mortality rate demonstrated that underlying mortality captured much, but not all, of the heterogeneity in treatment effects. The analysis demonstrates how to estimate localized treatment effects in large cluster-randomized trials and provides new insights into spatial heterogeneity in mortality and benefits of azithromycin distribution in Niger.
ER -